Delivery Order SPE2DR25D3501-SPE2DR26FL8RN
Award Date 11/13/25
Potential Completion Date 12/5/25
Potential Value $25K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $11,624.35 delivery order to AmerisourceBergen Drug Corp for the supply of Lorbrena 100 mg tablets (30-count packages) under a firm fixed-price contract. The delivery order is scheduled for completion by September 18, 2025, and will be fulfilled at AmerisourceBergen's Conshohocken, Pennsylvania facility. This award was competitively awarded with no set-aside designation, reflecting the vendor's capability to meet federal pharmaceutical procurement...
- The Defense Logistics Agency awarded a $24.5K delivery order to AmerisourceBergen Drug Corp for 30 tablets of Lorbrena 100 mg on October 22, 2025, with completion scheduled for November 13, 2025. This firm fixed-price contract, issued without set-aside provisions, will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical supply transaction supporting federal medical procurement needs through competitive award procedures. This...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $11,624.35 on October 29, 2025, for the supply of Lorbrena 100 mg tablets (30-count packaging). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of November 20, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Lorbrena 100 mg tablets in quantities of 30. This firm fixed-price delivery order, valued at $11,624.35, represents a competitive award with no set-aside designation and is scheduled for completion by September 16, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of Lorbrena 100 mg tablets (30-count packaging) with a ceiling value of $24,500.56. This competitively awarded, firm fixed-price delivery order was issued on November 13, 2025, with an ultimate completion date of December 5, 2025. The contract carries no set-aside designation and will be performed at...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,624.35 to AmerisourceBergen Drug Corp for the supply of Lorbrena 100 mg tablets (30-count units) with an ultimate completion date of August 19, 2025. This is a firm fixed price contract with no set-aside designation, awarded competitively on July 29, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of Lorbrena 100 mg tablets (30-count) valued at $11,624.35. This firm fixed-price delivery order, awarded on August 21, 2025, is scheduled for completion by September 12, 2025, with performance at the vendor's Conshohocken facility. The award represents a non-competitive, non-set-aside transaction, indicating it was...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Lorbrena 100mg tablets in quantities of 30 units. This firm fixed price delivery order, valued at $23,248.70, is scheduled for completion by August 11, 2025, with performance to be executed at the contractor's Conshohocken, Pennsylvania location. The award was made on a competitive basis with no set-aside designation, reflecting the contractor's...
- The Defense Logistics Agency awarded a $12.25K delivery order to AmerisourceBergen Drug Corp on November 14, 2025, for the supply of Lorbrena 100 mg tablets (30-count units) with delivery expected by December 8, 2025. This competitive award, which carries no set-aside designation, reflects AmerisourceBergen's role as a critical pharmaceutical distributor supporting federal medical procurement needs. The contract represents a firm fixed-price delivery order executed under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $11,624.35 delivery order to AmerisourceBergen Drug Corp for the supply of Lorbrena 100 mg tablets (30-count units) with a firm fixed price structure and an ultimate completion date of October 14, 2025. This non-set-aside, competitively awarded contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement valued through December 2026....